Thrombin increases expression of urokinase receptor by activation of the thrombin receptor.

PURPOSE To investigate the effect of thrombin on the urokinase plasminogen activator receptor (u-PAR) in retinal pigment epithelial (RPE) cells. METHODS The authors analyzed u-PAR mRNA by Northern blot hybridization. Retinal pigment epithelial cell surface u-PAR was assayed by measuring the amount of functional urokinase plasminogen activator (u-PA) bound to cells at saturation. Retinal pigment epithelial cells were derived from fetal retinal tissue and established in primary cell culture. RESULTS Thrombin increased u-PAR mRNA 4-fold in RPE cells examined by Northern blot hybridization, whereas the amount of thrombin receptor mRNA was unchanged. Thrombin stimulated u-PA binding to RPE cells 2.5- to 5-fold in a time- and dose-dependent manner. Hirudin, a thrombin antagonist, completely blocked the effects of thrombin on u-PAR expression in RPE cells. Phosphatidylinositol phospholipase C treatment of RPE cells resulted in the abolition of thrombin-induced u-PA binding. Recombinant soluble u-PAR competitively inhibited two-chain u-PA binding to the surface of thrombin-treated RPE cells. A thrombin receptor agonist peptide (SFLLRNPNDKYEPF) also induced a 2.5-fold increase in binding of u-PA to the surface of RPE cells. CONCLUSION Thrombin increases u-PAR expression by RPE cells by a mechanism involving activation of the seven transmembrane thrombin receptor.

[1]  D. Lawrence,et al.  Immunologic detection of the cellular receptor for urokinase plasminogen activator. , 1994, Clinical immunology and immunopathology.

[2]  Y. Zheng,et al.  Genetic predisposition to retinoblastoma (Rb). , 1993, Yan ke xue bao = Eye science.

[3]  P. Campochiaro,et al.  Modulation of plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells. , 1993, Investigative ophthalmology & visual science.

[4]  U. Reuning,et al.  Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[5]  B. Binder,et al.  Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1. , 1992, Cancer research.

[6]  A. Wakhloo,et al.  Microcatheter urokinase infusion in central retinal artery occlusion. , 1992, American journal of ophthalmology.

[7]  L. Brass,et al.  Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. , 1992, The Journal of biological chemistry.

[8]  F. Blasi,et al.  Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract , 1991, The Journal of cell biology.

[9]  D. Boyd,et al.  Regulation of the Urokinase Receptor by Its Plasminogen Activator , 1991, Thrombosis and Haemostasis.

[10]  F. Booyse,et al.  Urokinase binding and receptor identification in cultured endothelial cells. , 1991, The Journal of biological chemistry.

[11]  B. Gustavsson,et al.  Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumours. , 1991, European journal of cancer.

[12]  V. Wheaton,et al.  Domains specifying thrombin–receptor interaction , 1991, Nature.

[13]  P. Quax,et al.  Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation. , 1991, Cell regulation.

[14]  C. Esmon,et al.  The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. , 1991, The Journal of biological chemistry.

[15]  I. Mizukami,et al.  Purification, biochemical composition, and biosynthesis of the Mo3 activation antigen expressed on the plasma membrane of human mononuclear phagocytes. , 1991, Journal of immunology.

[16]  A. Levinson,et al.  Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells. , 1991, Blood.

[17]  D. Boyd,et al.  Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. , 1991, Cancer research.

[18]  D. Rifkin,et al.  Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor , 1991, The Journal of cell biology.

[19]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[20]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[21]  D. Weiner,et al.  Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA. , 1990, Blood.

[22]  K. Dyer,et al.  Retinal pigment epithelium cells can influence endothelial cell plasminogen activators. , 1990, Investigative ophthalmology & visual science.

[23]  E. Appella,et al.  The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. , 1990, The Journal of biological chemistry.

[24]  G. Lui,et al.  Propagation of fetal human RPE cells: Preservation of original culture morphology after serial passage , 1990, Journal of cellular physiology.

[25]  K. Hajjar,et al.  Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. , 1990, The Journal of biological chemistry.

[26]  E. Appella,et al.  Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. , 1990, The EMBO journal.

[27]  R. Tripathi,et al.  Extracellular release of tissue plasminogen activator is increased with the phagocytic activity of the retinal pigment epithelium. , 1989, Investigative ophthalmology & visual science.

[28]  J. Soria,et al.  Production of proteases type plasminogen activator and their inhibitor in cornea. , 1989, Biochemical and biophysical research communications.

[29]  I. Immonen,et al.  Tissue-type plasminogen activator in subretinal fluid. , 1989, Current eye research.

[30]  D. Belin,et al.  Characterization of the cellular binding site for the urokinase-type plasminogen activator. , 1989, The Journal of biological chemistry.

[31]  F. Blasi,et al.  A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification. , 1988, The Journal of biological chemistry.

[32]  R. Tripathi,et al.  Distribution of tissue plasminogen activator in human and monkey eyes. An immunohistochemical study. , 1987, Ophthalmology.

[33]  R. Nachman,et al.  Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. , 1987, The Journal of clinical investigation.

[34]  F. Blasi,et al.  Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors , 1987, The Journal of cell biology.

[35]  J. Baker,et al.  Thrombin interaction with platelets. Influence of a platelet protease nexin. , 1987, The Journal of biological chemistry.

[36]  G. Cassani,et al.  Binding of single-chain prourokinase to the urokinase receptor of human U937 cells. , 1986, The Journal of biological chemistry.

[37]  M. Shuman.  Thrombin‐Cellular Interactions , 1986, Annals of the New York Academy of Sciences.

[38]  R. M. Pino.  Immunocytochemical localization of fibronectin to the retinal pigment epithelium of the rat. , 1986, Investigative ophthalmology & visual science.

[39]  P. Campochiaro,et al.  Retinal pigment epithelial cells release an inhibitor of neovascularization. , 1985, Archives of ophthalmology.

[40]  D. Bok.  Retinal photoreceptor-pigment epithelium interactions. Friedenwald lecture. , 1985, Investigative ophthalmology & visual science.

[41]  A. Corti,et al.  Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Belin,et al.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase , 1985, The Journal of cell biology.

[43]  A. Adler,et al.  Proteins and glycoproteins of the bovine interphotoreceptor matrix: composition and fractionation. , 1982, Experimental eye research.

[44]  C. Esmon,et al.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[45]  G. Jamieson,et al.  Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface. , 1978, The Journal of biological chemistry.

[46]  I. Immonen,et al.  Retinal pigment epithelial cells secrete urokinase-type plasminogen activator and its inhibitor PAI-1. , 1992, Ophthalmic research.

[47]  P. Kessler,et al.  [Thrombolysis of arterial retinal occlusion using urokinase]. , 1992, Ceskoslovenska oftalmologie.

[48]  A. Mazar,et al.  Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines. , 1991, Cancer communications.

[49]  F. Blasi,et al.  The receptor for human urokinase: a potential target for anti-invasive and anti-metastatic therapy. , 1990, Thrombosis research. Supplement.

[50]  D. Boyd,et al.  Insensitivity of laminin degradation directed by receptor bound urokinase to PAI-1 in cultured colon cancer. , 1990, Cancer communications.

[51]  J. Mimuro,et al.  Type 1 plasminogen activator inhibitor. , 1989, Progress in hemostasis and thrombosis.

[52]  T. Gelehrter,et al.  Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. , 1986, The Journal of clinical investigation.